Grapow M T R, von Wattenwyl R, Zerkowski H-R
Division of Cardio-Thoracic Surgery, University Hospital of Basel, Spitalstrasse 21, 4031 Basel, Switzerland.
Clin Res Cardiol. 2006 Jan;95 Suppl 1:i31-4. doi: 10.1007/s00392-006-1101-4.
A variety of randomized, controlled trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) found similar results in mortality but significant differences in number of reinterventions in favor of CABG. This work gives an overview about the relevance and limitations of these studies in line with newly published large scale observational studies, which reveal significantly lower mortality-rates in CABG patients. Emphasis is placed on the special situation in the diabetic patient.
多项比较经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)的随机对照试验发现,两者在死亡率方面结果相似,但在再次干预次数上存在显著差异,CABG更具优势。本文结合新发表的大规模观察性研究,概述了这些研究的相关性和局限性,这些研究显示CABG患者的死亡率显著更低。重点关注糖尿病患者的特殊情况。